Cargando…
The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
Autores principales: | Sadasivam, Balakrishnan, Atal, Shubham, Ray, Avik, Sharma, Swati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451053/ https://www.ncbi.nlm.nih.gov/pubmed/32861824 http://dx.doi.org/10.1016/j.ijid.2020.08.058 |
Ejemplares similares
-
Exploring an unsung stigma factor in COVID-19
por: Ray, Avik, et al.
Publicado: (2020) -
Telephonic Triage in Times of COVID-19: Experiences at a Telemedicine Center in India
por: Ray, Avik, et al.
Publicado: (2021) -
Tigecycline-Induced Severe Hypoglycemia in a Non-Diabetic Individual: A Case Report and Brief Review of Tigecycline-Induced Severe Hypoglycemia
por: Ray, Avik, et al.
Publicado: (2020) -
Understanding the molecular–pharmaceutical basis of sartan recalls focusing on valsartan
por: Ray, Avik, et al.
Publicado: (2020) -
Medication concordance in modern medicine – A critical appraisal from an Indian perspective
por: Atal, Shubham, et al.
Publicado: (2019)